Cargando…
Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy
NF-E2-related factor 2 (NRF2) is a transcription factor that controls the expression of a variety of antioxidant and detoxification genes. Accumulating evidence strongly suggests that NRF2 mediates cancer cell proliferation and drug resistance, as well. Single nucleotide polymorphism (SNP) -617C >...
Autor principal: | Ishikawa, Toshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219421/ https://www.ncbi.nlm.nih.gov/pubmed/25408701 http://dx.doi.org/10.3389/fgene.2014.00383 |
Ejemplares similares
-
MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
por: Haque, Absarul, et al.
Publicado: (2020) -
Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021) -
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer
por: Chen, Xingyu, et al.
Publicado: (2020) -
The Application and Performance of Single Nucleotide Polymorphism Markers for Population Genetic Analyses of Lepidoptera
por: Coates, Brad Steven, et al.
Publicado: (2011) -
Genetic Diversity of Polymorphic Marker Merozoite Surface Protein 1 (Msp-1) and 2 (Msp-2) Genes of Plasmodium falciparum Isolates From Malaria Endemic Region of Pakistan
por: Khan, Shahid Niaz, et al.
Publicado: (2021)